Prudential Financial
AMLX icon

Prudential Financial’s Amylyx Pharmaceuticals AMLX Stock Holding History

Prudential Financial’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271K Buy
15,110
+990
+7% +$15.3K ﹤0.01% 2134
2026
Q1 		$196K Buy
+14,120
New +$199K ﹤0.01% 2147
2025
Q4 		– Sell
-10,155
Closed -$138K – 2222
2025
Q3 		$138K Sell
10,155
-5,465
-35% -$51.4K ﹤0.01% 2253
2025
Q2 		$100K Buy
15,620
+420
+3% +$2.04K ﹤0.01% 2284
2025
Q1 		$53.8K Sell
15,200
-4,200
-22% -$14.9K ﹤0.01% 2192
2024
Q4 		$73.3K Hold
19,400
– – ﹤0.01% 2175
2024
Q3 		$62.9K Buy
+19,400
New +$43.6K ﹤0.01% 2620

Other funds holding AMLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Prudential Financial's AMLX Position: Q2 2026 in Review

Prudential Financial increased its Amylyx Pharmaceuticals (AMLX) stake by 7% in Q2 2026, buying an estimated $15.3K and bringing the position to 15,110 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #2134.

Prudential Financial first reported a position in AMLX in Q3 2024 and has held it in 7 quarters since. 115 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Prudential Financial held 15,110 shares of Amylyx Pharmaceuticals worth $271K as of Q2 2026.
  • Prudential Financial bought 990 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $15.3K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2134 holding.
  • Prudential Financial first reported a position in Amylyx Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • 115 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.